Locations
Cambridge, MA, USA · England, UK · Oxford, UK · Oxfordshire, UK · West Street / River Street, Boston, MA, USA
industry
Biotechnology · Clinical Trials · Medical
Size
51 - 200 employees
Stage
IPO
founded in
2018
About

PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.

Something looks off?
Open jobs at Pepgen

On-site & Remote